Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

BI-D1870

S6 kinase inhibitor
 
BML-EI407-0001 1 mg 54.00 USD
 
BML-EI407-0005 5 mg 198.00 USD
Do you need bulk/larger quantities?
 
Cell permeable, ATP-competitive inhibitor of the four isoforms of ribosomal S6 kinase (p90 RSK) (IC50's at 100µM ATP: RSK1 = 31nM, RSK2 = 24nM, RSK3 = 18nM, RSK4 = 15nM). Does not significantly inhibit 10 other AGC kinases, and over 40 other protein kinases at 100X concentrations. Acts on the N-terminal AGC kinase domain. Completely prevents PMA-induced TSC2 phosphorylation.

Product Specification

Alternative Name:2-[(3,5-Difluoro-4-hydroxyphenyl)amino]-7,8-dihydro-5,7-dimethyl-8-(3-methylbutyl)-6(5H)-pteridone
 
Formula:C19H23F2N5O2
 
MW:391.4
 
CAS:501437-28-1
 
Purity:≥98% (HPLC)
 
Appearance:Off-white solid.
 
Solubility:Soluble in DMSO (>25mg/ml).
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:-20°C
 
Use/Stability:Stable for at least one year from the date of receipt when stored as supplied at -20°C
 
Handling:Solutions can be stored at -20°C for up to 3 months. Protect from moisture and light.
 
BML-EI407 structure
Please mouse over
BML-EI407 structure

Product Literature References

ERK and RSK are necessary for TRH-induced inhibition of r-ERG potassium currents in rat pituitary GH3 cells: L. Carretero, et al.; Cell. Signal. 27, 1720 (2015), Application(s): Cell Culture, Abstract;
BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in vitro and in vivo: G. Sapkota, et al.; Biochem. J. 401, 29 (2007), Abstract; Full Text

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
S6 kinase
By biological activity:
S6 kinase Inhibitor
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Brochures
Stem Cells
Stem Cells
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,